März, W. (2018). Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Atherosclerosis, 268, . https://doi.org/10.1016/j.atherosclerosis.2017.11.020
Chicago Style (17th ed.) CitationMärz, Winfried. "Utilization of Lipid-modifying Therapy and Low-density Lipoprotein Cholesterol Goal Attainment in Patients at High and Very-high Cardiovascular Risk: Real-world Evidence from Germany." Atherosclerosis 268 (2018). https://doi.org/10.1016/j.atherosclerosis.2017.11.020.
MLA (9th ed.) CitationMärz, Winfried. "Utilization of Lipid-modifying Therapy and Low-density Lipoprotein Cholesterol Goal Attainment in Patients at High and Very-high Cardiovascular Risk: Real-world Evidence from Germany." Atherosclerosis, vol. 268, 2018, https://doi.org/10.1016/j.atherosclerosis.2017.11.020.